London Business Angels (LBA)

SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.

Momentum Bioscience Ltd is a biotechnology company specializing in the development of rapid diagnostic tests for critical clinical specimens. Established in 2005 and based in Cardiff, United Kingdom, the company utilizes its innovative Enzyme Mediated Amplification (EMA) technology to enable the universal detection of viable bacteria and fungi in under two hours, significantly reducing the time compared to traditional laboratory methods that can take 1 to 5 days. Momentum Bioscience's products are particularly valuable in neonatal care, emergency care, and critical care settings, as they specifically measure viable organisms, ensuring accurate detection of infections in blood and other normally sterile body fluids. The company is focused on advancing its suite of related technologies to enhance pathogen detection and support microbiology laboratories.